Ovarian Cancer Clinical Trial
Spanish Decision Tool for Ovarian Cancer Maintenance Therapy
Summary
To develop a shared decision-making (SDM) tool to help Spanish-speaking patients make decisions about their maintenance therapy
Full Description
Objectives:
Create a low literacy version of a shared decision-making (SDM) tool for ovarian cancer maintenance therapy for Spanish speaking individuals.
To explore the feasibility and acceptability of incorporating the SDM tool into routine clinical care for Spanish speaking individuals.
To estimate the effectiveness of the SDM tool on quality of the decision making in patients with ovarian cancer who are making decisions about maintenance therapy through a pilot study.
Eligibility Criteria
Study population: This study will enroll patients and clinical providers.
Inclusion criteria: Patients
• Eligible patients must be: 1) individuals ≥ 18 years with advanced stage high grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are receiving or have completed platinum-based chemotherapy for ovarian cancer and are potentially eligible to receive maintenance therapy; 2) able to understand, speak or read in Spanish.
Exclusion criteria: Patients
• Inability or unwillingness to sign informed consent
Inclusion criteria: Clinicians
• Eligible clinicians will include: 1) MD Anderson gynecologic oncologists and advanced practice providers who practice at the Houston Area Locations (HALs), MD Anderson Cancer Center, or our county safety net hospital, The Harris Health System (LBJ Hospital).
Exclusion criteria: Clinicians
• Inability or unwillingness to sign informed consent
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Houston Texas, 77030, United States More Info
Principal Investigator
How clear is this clinincal trial information?